Oversight (Overview)
The Institutional Biosafety Committee (IBC) is responsible for the review of University research or teaching activities involving recombinant or synthetic nucleic acid molecules, potentially hazardous infectious agents, and potentially hazardous biologically-derived toxins as described in the University of Minnesota Board of Regents Policy and the administrative policy. The IBC reviews proposed research and teaching activities for compliance with the NIH Guidelines and the BMBL and approves the proposed research or teaching activities found to conform with the NIH Guidelines and the BMBL.
Application Process
Use eProtocol to create and submit an IBC application. Learn more about the application process and guidelines for completing an IBC application in eProtocol.
Meeting Dates & Application Submission Deadlines
The IBC committee meets once a month to review applications. The application submission deadline is typically the last Wednesday of the month. Learn more about the upcoming IBC meeting dates and submission deadlines.
IBC Committee
The IBC Committee members include faculty, staff and community representatives with combined expertise in areas ranging from DNA technology, virology, plant biology, and animal containment. Learn more about the power of the committee and how to become a member.
IBC Policies
Learn about the policies and procedures related to the IBC committee.